These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


635 related items for PubMed ID: 15312167

  • 1. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S.
    J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
    [Abstract] [Full Text] [Related]

  • 2. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons.
    Bertran-Gonzalez J, Håkansson K, Borgkvist A, Irinopoulou T, Brami-Cherrier K, Usiello A, Greengard P, Hervé D, Girault JA, Valjent E, Fisone G.
    Neuropsychopharmacology; 2009 Jun; 34(7):1710-20. PubMed ID: 19158668
    [Abstract] [Full Text] [Related]

  • 3. Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death.
    Giordano G, Sánchez-Pérez AM, Montoliu C, Berezney R, Malyavantham K, Costa LG, Calvete JJ, Felipo V.
    J Neurochem; 2005 Aug; 94(3):808-18. PubMed ID: 16000164
    [Abstract] [Full Text] [Related]

  • 4. Degree of immediate early gene induction in striatum by eticlopride determines sensitivity to N-methyl-D-aspartate receptor blockade.
    Adams AC, Keefe KA.
    Brain Res; 2000 Dec 08; 885(2):201-7. PubMed ID: 11102574
    [Abstract] [Full Text] [Related]

  • 5. Calcium-dependent, D2 receptor-independent induction of c-fos by haloperidol in dopamine neurons.
    Jomphe C, Lévesque D, Trudeau LE.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May 08; 367(5):480-9. PubMed ID: 12695877
    [Abstract] [Full Text] [Related]

  • 6. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP, Dorsa DM.
    Neuroscience; 1999 Mar 08; 89(3):927-38. PubMed ID: 10199625
    [Abstract] [Full Text] [Related]

  • 7. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.
    Konradi C, Leveque JC, Hyman SE.
    J Neurosci; 1996 Jul 01; 16(13):4231-9. PubMed ID: 8753884
    [Abstract] [Full Text] [Related]

  • 8. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors.
    Liste I, Rozas G, Guerra MJ, Labandeira-Garcia JL.
    Brain Res; 1995 Nov 27; 700(1-2):1-12. PubMed ID: 8624698
    [Abstract] [Full Text] [Related]

  • 9. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S, Hashimoto K, Hattori K, Yuasa S, Iyo M.
    Brain Res; 2004 Jun 11; 1011(1):84-93. PubMed ID: 15140647
    [Abstract] [Full Text] [Related]

  • 10. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling.
    Pan B, Hillard CJ, Liu QS.
    J Neurosci; 2008 Dec 24; 28(52):14018-30. PubMed ID: 19109485
    [Abstract] [Full Text] [Related]

  • 11. Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons.
    Hamada M, Higashi H, Nairn AC, Greengard P, Nishi A.
    J Neurochem; 2004 Sep 24; 90(5):1094-103. PubMed ID: 15312165
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic enhancement of excitatory synaptic transmission in layer II entorhinal neurons is dependent on D₁-like receptor-mediated signaling.
    Glovaci I, Caruana DA, Chapman CA.
    Neuroscience; 2014 Jan 31; 258():74-83. PubMed ID: 24220689
    [Abstract] [Full Text] [Related]

  • 13. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J, Rajakumar N.
    Neuroscience; 2003 Jan 31; 122(3):739-45. PubMed ID: 14622917
    [Abstract] [Full Text] [Related]

  • 14. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons.
    Dell'anno MT, Pallottino S, Fisone G.
    Neuropharmacology; 2013 Mar 31; 66():179-86. PubMed ID: 22507666
    [Abstract] [Full Text] [Related]

  • 15. Examination of the involvement of protein kinase A in D2 dopamine receptor antagonist-induced immediate early gene expression.
    Adams AC, Keefe KA.
    J Neurochem; 2001 Apr 31; 77(1):326-35. PubMed ID: 11279288
    [Abstract] [Full Text] [Related]

  • 16. Regulation of neuronal differentiation by N-methyl-D-aspartate receptors expressed in neural progenitor cells isolated from adult mouse hippocampus.
    Kitayama T, Yoneyama M, Tamaki K, Yoneda Y.
    J Neurosci Res; 2004 Jun 01; 76(5):599-612. PubMed ID: 15139019
    [Abstract] [Full Text] [Related]

  • 17. D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors.
    Price CJ, Kim P, Raymond LA.
    J Neurochem; 1999 Dec 01; 73(6):2441-6. PubMed ID: 10582604
    [Abstract] [Full Text] [Related]

  • 18. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
    Hussain N, Flumerfelt BA, Rajakumar N.
    Neuroscience; 2001 Dec 01; 102(2):391-9. PubMed ID: 11166125
    [Abstract] [Full Text] [Related]

  • 19. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Strauss JB.
    Brain Res; 1999 May 08; 827(1-2):160-8. PubMed ID: 10320705
    [Abstract] [Full Text] [Related]

  • 20. Glutamatergic induction of CREB phosphorylation and Fos expression in primary cultures of the suprachiasmatic hypothalamus in vitro is mediated by co-ordinate activity of NMDA and non-NMDA receptors.
    Schurov IL, McNulty S, Best JD, Sloper PJ, Hastings MH.
    J Neuroendocrinol; 1999 Jan 08; 11(1):43-51. PubMed ID: 9918228
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.